ASX - By Stock
|
PER |
Re:
Ann: Positive feedback received on Paediatric Investigation Plan
|
|
stringless
|
221 |
82K |
9 |
30/09/21 |
30/09/21 |
ASX - By Stock
|
221
|
82K
|
9
|
|
ASX - By Stock
|
EVS |
Re:
Further Good News for EVS Holders
|
|
stringless
|
43 |
13K |
3 |
22/09/21 |
22/09/21 |
ASX - By Stock
|
43
|
13K
|
3
|
|
ASX - By Stock
|
PER |
Re:
Ann: Quarterly Report and Appendix 4C
|
|
stringless
|
60 |
15K |
0 |
18/08/21 |
18/08/21 |
ASX - By Stock
|
60
|
15K
|
0
|
|
ASX - By Stock
|
PER |
Re:
Ann: ANP Updates on US Regulatory Plans for ATL1102 in DMD
|
|
stringless
|
174 |
47K |
6 |
13/08/21 |
13/08/21 |
ASX - By Stock
|
174
|
47K
|
6
|
|
ASX - By Stock
|
PER |
Re:
Ann: ANP Updates on US Regulatory Plans for ATL1102 in DMD
|
|
stringless
|
174 |
47K |
6 |
12/08/21 |
12/08/21 |
ASX - By Stock
|
174
|
47K
|
6
|
|
ASX - By Stock
|
VHT |
Re:
Ann: VOLPARA COLLABORATES WITH LEADING GENETICS COMPANY, INVITAE
|
|
stringless
|
5 |
3.3K |
0 |
21/07/21 |
21/07/21 |
ASX - By Stock
|
5
|
3.3K
|
0
|
|
Charts
|
PER |
Re:
Chart
|
|
stringless
|
5.9K |
2.3M |
0 |
04/06/21 |
04/06/21 |
Charts
|
5.9K
|
2.3M
|
0
|
|
ASX - By Stock
|
NC6 |
Re:
General Discussion
|
|
stringless
|
1.3K |
361K |
0 |
21/01/21 |
21/01/21 |
ASX - By Stock
|
1.3K
|
361K
|
0
|
|
ASX - By Stock
|
NC6 |
Re:
General Discussion
|
|
stringless
|
1.3K |
361K |
4 |
18/01/21 |
18/01/21 |
ASX - By Stock
|
1.3K
|
361K
|
4
|
|
Charts
|
PER |
Re:
Chart
|
|
stringless
|
5.9K |
2.3M |
21 |
17/01/21 |
17/01/21 |
Charts
|
5.9K
|
2.3M
|
21
|
|
ASX - By Stock
|
PLS |
Re:
Ann: Completion of Retail Entitlement Offer
|
|
stringless
|
202 |
94K |
2 |
15/01/21 |
15/01/21 |
ASX - By Stock
|
202
|
94K
|
2
|
|
Charts
|
PER |
Re:
Chart
|
|
stringless
|
5.9K |
2.3M |
3 |
13/01/21 |
13/01/21 |
Charts
|
5.9K
|
2.3M
|
3
|
|
Charts
|
PER |
Re:
Chart
|
|
stringless
|
5.9K |
2.3M |
3 |
13/01/21 |
13/01/21 |
Charts
|
5.9K
|
2.3M
|
3
|
|